LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A-H2B-mCherry | Neratinib | 1 | 17.28 | 27.76 | 11 | 838 | 0.0131 | -0.1716 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 17.28 | 27.76 | 728 | 838 | 0.8680 | 0.9432 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 17.28 | 27.76 | 1 | 838 | 0.0012 | -0.4913 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 17.28 | 27.76 | 247 | 838 | 0.2945 | 0.5598 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 18.98 | 27.76 | 12 | 941 | 0.0128 | -0.1521 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 18.98 | 27.76 | 748 | 941 | 0.7948 | 0.9116 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 18.98 | 27.76 | 1 | 941 | 0.0011 | -0.4799 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 18.98 | 27.76 | 310 | 941 | 0.3294 | 0.6075 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 20.68 | 27.76 | 10 | 1119 | 0.0089 | -0.1742 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 20.68 | 27.76 | 722 | 1119 | 0.6452 | 0.8423 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 20.68 | 27.76 | 1 | 1119 | 0.0009 | -0.4638 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 20.68 | 27.76 | 417 | 1119 | 0.3727 | 0.6621 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 22.39 | 27.76 | 21 | 1305 | 0.0161 | -0.0490 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 22.39 | 27.76 | 796 | 1305 | 0.6096 | 0.8296 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 22.39 | 27.76 | 1 | 1305 | 0.0008 | -0.4502 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 22.39 | 27.76 | 513 | 1305 | 0.3929 | 0.6905 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 24.09 | 27.76 | 24 | 1461 | 0.0164 | -0.0251 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 24.09 | 27.76 | 681 | 1461 | 0.4659 | 0.7500 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 24.09 | 27.76 | 1 | 1461 | 0.0007 | -0.4408 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 24.09 | 27.76 | 557 | 1461 | 0.3811 | 0.6895 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 25.79 | 27.76 | 15 | 1605 | 0.0093 | -0.0998 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 25.79 | 27.76 | 721 | 1605 | 0.4492 | 0.7444 | MN20160318_Q01 | E14 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 25.79 | 27.76 | 1 | 1605 | 0.0006 | -0.4332 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 25.79 | 27.76 | 601 | 1605 | 0.3744 | 0.6910 | MN20160318_Q01 | H08 |
MCF 10A-H2B-mCherry | Neratinib | 1 | 27.49 | 27.76 | 22 | 1723 | 0.0128 | -0.0383 | MN20160318_Q01 | E14 |